Skip to content
Company Analysis

Adagio Medical Holdings, Inc ADGM

A comprehensive view of key metrics, scores, and financial health for Adagio Medical Holdings, Inc

Overview of Adagio Medical Holdings, Inc.

ADGM NCM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap
Adagio Medical Holdings, Inc. (ADGM), is a Micro Cap company, in the Medical Devices industry, last closed at $0.74, about 0.0% overvalued vs fair value, -31.7% 1Y return, ranked 1092/1122 in sector.
USD 0.75
-3.50%
(Delayed)
• Vol 90d: 98.0%
52-Week Range
Market Cap
$16.74M
Enterprise Value
$21.39M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Completeness: 70%
Confidence: 82%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://adagiomedical.com
HQ Laguna Hills, CA
Employees 80
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Revenue data missing or non-positive

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$0
-100%%
Free Cash Flow
$-19.4M
25.4%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

FCF Conversion
77%
Fair

Free Cash Flow / Net Income — MedTech quality hallmark. ≥100% is typical and desirable; M&A amortisation makes GAAP NI lower than true cash earnings.

Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
1/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Adagio Medical Holdings, Inc's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
16
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Weak
2
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 83% Coverage
Trade-Off Triangle Visualization A ternary plot showing ADGM's balance between Growth (32.9%), Profitability (14.1%), and Safety (53.1%). Growth 33% Safety 53% Profitability 14%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

26th percentile vs peers
26
Key Signals
Revenue CAGR 3Y -0.1% 31p Rev Growth YoY -10.3% 18p Asset Growth YoY 6.10 99p EPS Growth YoY -61.1% 15p
Strengths
  • D/E Ratio in top 20% of peers (81.7%, 81th percentile)
  • Conservative leverage compared to industry peers
Risks
  • Rev Growth YoY in bottom 20% of peers (-10.3%)
  • EPS Growth YoY in bottom 20% of peers (-61.1%)

Profitability

11th percentile vs peers
11
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

42th percentile vs peers
42
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Adagio Medical Holdings, Inc.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000